Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

May 22 2001
Washington, D.C. (May 22, 2001) – Bernice Welles, M.D., will speak on behalf of the Biotechnology Industry Organization Wednesday at a Senate hearing to...
May 17 2001
WASHINGTON, D.C. (May 17, 2001) – Skyrocketing gasoline, home heating oil and natural gas prices underscore the importance of developing renewable energy...
May 16 2001
WASHINGTON, D.C. (May 16, 2001) -- It is likely that PresidentBush and Vice President Cheney will include bioenergy development in their new energy policy....
May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Robert Chess, chairman of Inhale Therapeutic Systems, based in San Carlos, Calif., is scheduled to testify on behalf of the...
May 15 2001
WASHINGTON, D.C. (May 15, 2001) – Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO) today released the following statement in...
May 14 2001
WASHINGTON, D. C. (May 14, 2001) – More than 200 meetings with Capitol Hill legislators are scheduled for biotechnology industry representatives during the...
May 11 2001
WASHINGTON, D.C. (May 11, 2001) – The U.S. Senate passed a resolution (attached) declaring May 13 – 20 National Biotechnology Week, thereby recognizing...
May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Biotechnology Industry Organization (BIO) President Carl B. Feldbaum today issued the following statement after congressional...
May 10 2001
WASHINGTON, D.C. (May 10, 2001) – Lila Feisee, director of government relations and intellectual property at the Biotechnology Industry Organization (BIO),...


Biotechnology News

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a...

September 19, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30...

September 19, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative...